Yeast Beta-glucan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others), By Region and Competition, 2020-2030F

Market Overview

Global Yeast Beta-glucan Market was valued at USD 192.32 million in 2024 and is expected to reach USD 305.20 million in the forecast period with a CAGR of 7.96% through 2030. The rising consumer awareness around preventive healthcare and immunity enhancement is a key driver for the growth of the yeast beta-glucan market. Derived from the cell walls of baker’s yeast, this bioactive compound is known for its ability to boost immune response, making it a popular additive in dietary supplements, functional foods, and health drinks. Post-pandemic lifestyle changes have intensified demand for natural immune boosters, encouraging manufacturers to incorporate yeast beta-glucan into mainstream wellness products.

Another major factor contributing to market expansion is the increasing use of yeast beta-glucan in pharmaceutical and personal care applications. Its anti-inflammatory, wound-healing, and antioxidant properties make it highly suitable for skin care formulations and therapeutic drugs. As consumers shift toward clean-label and scientifically backed ingredients, cosmetic and pharma companies are investing in yeast beta-glucan to enhance the efficacy and appeal of their products, thereby widening the ingredient’s end-use potential.

Key Market Drivers

Expanding Functional Foods and Nutraceuticals Industry

The growing focus on preventive health and wellness is significantly boosting the demand for functional foods and nutraceuticals, with yeast beta-glucan gaining prominence as a versatile and evidence-backed ingredient. According to a 2023 survey by FMCG Gurus, 64% of global consumers reported using functional foods to support their immune health. Additionally, nearly 58% of consumers stated they prefer natural bioactives in supplements. Yeast beta-glucan, known for its immune-modulating and cholesterol-lowering benefits, aligns well with these consumer preferences.

Yeast beta-glucan is increasingly incorporated into an array of functional products ranging from granola bars and dairy alternatives to meal-replacement drinks and fortified bakery items. Its neutral taste and excellent solubility allow seamless integration without altering flavor profiles, making it ideal for diverse formulations. Beyond functional foods, nutraceuticals such as capsules and drink powders are being enriched with yeast beta-glucan to target heart health, immunity, and metabolic wellness. As public health concerns continue to rise, this ingredient’s wide-ranging applications make it a staple in forward-looking health product development.

As research supporting the efficacy of yeast beta-glucan grows, so does consumer trust in its benefits. Clinical studies have shown that yeast beta-glucan can significantly reduce the duration and severity of upper respiratory tract infections and help modulate the immune response. This scientific validation is crucial in a market where 63% of global consumers say they trust health claims more when supported by research, according to a 2023 Kerry Health and Nutrition Institute report. As a result, brands are leveraging these studies to position their products as science-backed wellness solutions.

In addition to its physiological benefits, yeast beta-glucan offers manufacturers production and labeling advantages. It is gluten-free, vegan, and allergen-friendly—fitting the clean-label trend that dominates consumer choices. With regulatory approvals in major regions including the U.S., EU, and Japan, it enjoys a favorable position for global market expansion. This adaptability allows manufacturers to formulate for various demographics, including aging populations, athletes, and health-conscious millennials, thereby maximizing market penetration and driving sustained demand for yeast beta-glucan across diverse applications.

Pharmaceutical and Biotechnology Industries

The global yeast beta-glucan market is experiencing significant growth, thanks to its versatile applications in various industries. Among the sectors contributing to its expansion, the pharmaceutical and biotechnology industries play a pivotal role. The pharmaceutical industry has recognized the potential of yeast beta-glucan as an effective drug delivery system. Its unique properties, such as its ability to encapsulate and protect sensitive drugs, make it an attractive choice for pharmaceutical formulations. Yeast beta-glucan can serve as a carrier for both hydrophilic and hydrophobic drugs, facilitating targeted and controlled drug release. As pharmaceutical companies seek innovative drug delivery solutions, yeast beta-glucan emerges as a valuable asset. In the biotechnology sector, yeast beta-glucan's immunomodulatory properties are garnering significant interest. It can act as an adjuvant, enhancing the effectiveness of vaccines by stimulating the immune system. This application is particularly relevant in the development of vaccines for infectious diseases, cancers, and autoimmune disorders. As the biotechnology industry continues to advance in vaccine research, yeast beta-glucan is poised to play a crucial role in improving vaccine efficacy. The pharmaceutical and biotechnology industries are actively exploring yeast beta-glucan's potential in managing inflammatory conditions and autoimmune diseases. Studies have shown that yeast beta-glucan can modulate the immune system, reducing inflammation and promoting overall health. This makes it a promising candidate for the development of therapies aimed at addressing autoimmune disorders and chronic inflammatory conditions. Both industries heavily rely on rigorous clinical trials and research to develop new therapies and drugs. Yeast beta-glucan's safety profile and well-documented health benefits make it an attractive option for inclusion in clinical trials. As more research substantiates its efficacy, it gains credibility as a therapeutic agent, further increasing its demand from pharmaceutical and biotech companies. The pharmaceutical and biotechnology industries are increasingly recognizing the value of natural and sustainable ingredients. Yeast beta-glucan, derived from yeast cell walls through a fermentation process, aligns with this sustainability trend. Its eco-friendly production process and compatibility with green chemistry principles make it an appealing choice for companies committed to sustainable practices.

Rising Health Consciousness

Rising health consciousness is significantly transforming consumer preferences, with over 67% of global consumers actively seeking food and beverage products that provide health benefits, according to a 2023 FMCG Gurus survey. This behavioral shift is strongly influencing the demand for yeast beta-glucan—a naturally derived polysaccharide known for its immune-boosting and cholesterol-lowering properties. As individuals increasingly pursue diets that offer functional advantages beyond basic nutrition, yeast beta-glucan is becoming a go-to ingredient in wellness-focused products.

Furthermore, 53% of consumers worldwide are willing to pay more for products with recognized health claims, highlighting their commitment to proactive health management. Yeast beta-glucan aligns well with these priorities as it supports immune function and cardiovascular health while being compatible with clean-label, non-GMO, and plant-based trends. Its broad applicability across dietary supplements, bakery items, fortified beverages, and even skincare products ensures its expanding presence across industries. This convergence of rising health awareness and diverse product formulation possibilities positions yeast beta-glucan as a standout ingredient in today’s health-driven market landscape.

The growing prevalence of lifestyle-related health conditions such as obesity, diabetes, and cardiovascular diseases has further intensified interest in preventive nutrition. Consumers are now adopting a “food as medicine” approach, integrating ingredients like yeast beta-glucan into their daily diets to reduce health risks naturally. Yeast beta-glucan’s clinically backed benefits in immune modulation and cholesterol reduction make it an ideal component in both functional foods and nutraceuticals aimed at preventing such conditions. This preventive mindset is especially strong among aging populations, who prioritize ingredients that support long-term health and wellness.

In addition to its health benefits, yeast beta-glucan aligns with the surge in demand for sustainable and ethical sourcing. As more consumers inquire about the environmental footprint of their dietary choices, manufacturers are turning to ingredients with minimal ecological impact. Yeast beta-glucan, typically a byproduct of fermentation processes, offers a low-waste, eco-friendly solution. Its clean-label appeal and compatibility with vegan and allergen-free product lines enhance its marketability to a broad range of conscious consumers. This intersection of health benefits, ethical production, and environmental sustainability continues to drive the adoption of yeast beta-glucan across global markets.

Download Free Sample Report

Key Market Challenges

Regulatory Complexity

Regulatory complexity poses a significant challenge in the global yeast beta-glucan market, particularly as the ingredient is used in diverse applications such as functional foods, dietary supplements, pharmaceuticals, and cosmetics. Different countries and regions have distinct regulatory frameworks governing the approval, labeling, and permissible usage levels of bioactive ingredients like yeast beta-glucan. For instance, while it may be classified as a dietary supplement in one market, it may require novel food approval in another. Navigating these varying standards creates compliance burdens for manufacturers and delays product launches.

Moreover, securing regulatory approvals often involves rigorous clinical documentation and costly testing to validate health claims, especially for immune-boosting or cholesterol-lowering properties. Smaller players in the market may struggle to meet these requirements, hindering innovation and competitiveness. Frequent changes in labeling regulations, safety thresholds, and permissible claims further add to the uncertainty, making global expansion a complex task. As the demand for yeast beta-glucan grows, harmonizing regulations across markets remains critical to unlocking its full commercial potential.

In addition to the fragmented global regulations, manufacturers of yeast beta-glucan face hurdles in gaining recognition for functional claims, particularly in regions with stringent health claim laws such as the European Union. The European Food Safety Authority (EFSA), for instance, requires robust scientific evidence to approve health benefit claims on product labels. While yeast beta-glucan has shown promising results in immunity and cholesterol reduction, the inconsistency in clinical data formats or study populations can lead to delays or rejections in approvals. This not only slows down product development cycles but also adds to the cost and risk of market entry.

Furthermore, regulatory complexity impacts branding and marketing strategies. Companies must tailor product formulations, packaging, and communication for each region to align with local laws. For example, a product marketed as "immune-supporting" in the U.S. may not be allowed to carry the same claim in Asia without country-specific approval. These adjustments reduce economies of scale and complicate supply chains. As consumer awareness grows, inconsistent messaging due to regulatory constraints may also affect consumer trust and brand credibility, making it vital for companies to invest in region-specific regulatory expertise and strategic planning.

Key Market Trends

Animal Nutrition and Health

In a world where the quality and safety of animal-derived products are paramount, the animal nutrition and health industry has been increasingly focusing on natural and sustainable solutions. Yeast beta-glucan, a natural polysaccharide derived from yeast cell walls, has emerged as a key player in promoting the well-being of livestock and aquatic species. One of the fundamental factors driving the demand for yeast beta-glucan in animal nutrition is its ability to enhance the immune system of animals. This natural compound is known for its immunomodulatory properties, which strengthen the immune response in livestock and aquaculture species. As the livestock industry seeks to reduce the use of antibiotics and other synthetic additives, yeast beta-glucan offers a natural alternative to support animal health. A robust digestive system is essential for animal health and productivity. Yeast beta-glucan has been shown to positively impact gut health by promoting beneficial gut microflora and improving nutrient absorption. This is particularly important in poultry and swine production, where efficient digestion plays a crucial role in animal growth and overall health. Stress can have a detrimental effect on animal health and productivity. Yeast beta-glucan has been found to mitigate the negative impacts of stress in animals by modulating the stress response. This is particularly relevant in the aquaculture industry, where stress due to environmental factors can significantly impact fish and shrimp health. As the aquaculture industry continues to grow, the demand for yeast beta-glucan to reduce stress and improve the overall well-being of aquatic species is on the rise. Consumer awareness and demand for sustainably sourced animal products have increased significantly in recent years. Yeast beta-glucan, derived from yeast cell walls, aligns with these sustainability goals as it is produced through an environmentally friendly fermentation process. As consumers seek out animal products that are produced using sustainable and eco-friendly practices, the inclusion of yeast beta-glucan in animal diets becomes an attractive proposition for producers. Many regulatory bodies have approved the use of yeast beta-glucan in animal feed, further supporting its adoption in the animal nutrition industry. This regulatory approval provides a level of confidence for feed manufacturers and livestock producers, encouraging them to incorporate yeast beta-glucan into animal diets.

Segmental Insights

Application Insights

Based on the category of Application, the food and beverage sector were the dominant force in the market in 2024 and is expected to maintain its leading position throughout the projected period. The primary driver for market growth during this time is the rising consumption of functional foods and dietary supplements worldwide. The affordability of the product is predicted to be a major factor driving demand for its use in animal feed applications. The segment related to animal feed is anticipated to experience the highest growth rate in terms of revenue during the forecast period. The key advantages of the product include bolstering the immune system of animals, increasing antibody levels following vaccinations, and enhancing resistance to microbial infections.

In the personal care and cosmetics sector, the product is primarily utilized in skincare products such as moisturizers, toners, conditioners, and sunscreen lotions. The increasing spending by consumers, particularly among women in developing countries, is expected to create new opportunities for the product in personal care and cosmetics applications.

Download Free Sample Report

Regional Insights

In 2024, Asia Pacific secured the largest portion of revenue. This can be attributed to the presence of numerous companies engaged in food processing, cosmetics, and personal care product manufacturing across Asian nations like India, China, South Korea, and Japan.

The region boasts a significant diversity in terms of income levels, demographics, and dietary preferences. The increasing demand for food products enriched with higher nutritional value, along with the growing disposable income of consumers, is expected to positively influence the industry's growth.

Meanwhile, the Middle East and Africa are projected to witness the swiftest revenue growth in the forecast period. The GCC (Gulf Cooperation Council) countries, in particular, are experiencing a rising demand for healthy food products with clear ingredient labels. Consequently, the demand for natural ingredients like yeast beta-glucan is anticipated to surge in the coming years.

Saudi Arabia and the U.A.E. serve as focal points for processed food products in this region. The younger generation in GCC countries is displaying a preference for healthier and natural products, which is expected to drive market growth throughout the forecast period.

Recent Developments

• In February 2025, Layn Natural Ingredients has unveiled an expanded biotechnology facility in Guangxi, China, enhancing its precision fermentation and enzyme-based production capabilities. The first product from this investment is Galacan, a next-generation, water-soluble beta-glucan heteropolysaccharide with superior bioavailability. Positioning the company at the forefront of sustainable innovation, this launch supports applications across supplements, functional foods, personal care, and animal nutrition.
• In December 2024, Witsbb has introduced an Elderberry Yeast β‑glucan drink tailored for sensitive children aged 6 months to 12 years. The formulation combines patented elderberry extract, yeast β‑glucan, and pear extract, offering gut health and immune support without common allergens. Designed for pediatric use, the allergen-free drink exemplifies Witsbb’s focus on innovative, child-friendly nutritional beverages. 
• In December 2024, Yeastup, a Swiss innovator in yeast-derived ingredients, has secured CHF 8.9 million in Series A funding to establish a large-scale production facility by repurposing a former dairy site in Switzerland. The new plant will upcycle over 20,000 tons of brewer’s spent yeast annually, extracting high-quality protein, beta‑glucan, and mannoprotein via a patented process. This scalable, eco‑friendly approach supports applications across food, nutraceutical, and cosmetic industries.
• In May 2024, Ohly has launched its NEIVA health range, a line of powdered yeast-based ingredients designed to support immune and cardiovascular wellness. The debut products—NEIVA Glucan Max (yeast beta-glucans) and NEIVA MCT Immune (functional lipids)—offer free-flowing, flavor-neutral formulations ideal for functional foods, sports nutrition, and dietary supplements, reflecting Ohly's expertise in clean, versatile, and science-backed ingredients.

Key Market Players

• Cargill Inc
• Lesaffre Yeast Corp
• EMD Millipore Corp
• Biorigin USA LLC
• Kerry Group PLC
• Lallemand Inc
• Specialty Biotech Co.,LTD.
• VW-Ingredients
• Angel Yeast Co., Ltd.
• Leiber GmbH

Report Scope:

In this report, the Global Yeast Beta-glucan Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Yeast Beta-glucan Market, By Application:

o   Food & Beverages

o   Personal Care & Cosmetics

o   Pharmaceuticals

o   Animal Feed

o   Others

• Yeast Beta-glucan Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Yeast Beta-glucan Market.

Available Customizations:

Global Yeast Beta-glucan market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Yeast Beta-glucan Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]